Description
Tirzepatide is a synthetic peptide designed to engage both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor pathways. These signalling systems are widely studied in nutrient handling, glucose regulation and energy-balance research.
MMRR Tirzepatide is listed as a research material. Vial size and pricing will be added to the catalogue when finalized. Every MMRR batch is independently third-party tested under the MMRR testing program.
Manufactured in Atlantic Canada. For research purposes only. No dosing or medical-use guidance is provided.





Reviews
There are no reviews yet.